Comments 
Print 
Mail 
Large Medium SmallGlaxoSmithKleine, the British pharmaceutical giant, said it was committed to China and denied media reports that it is considering pulling out over potential fines following a bribery scandal.
British newspaper the Daily Telegraph reported that the company is considering whether to leave China, where an ongoing criminal investigation may leave the company facing fines as high as 20 billion yuan ($3.27 billion) and the severance of ties with major hospitals.
"GSK has a long history in China - we have been present in the country since the early 1900's. We remain committed to China for the long term," GSK China replied in an email interview with China Daily on Monday.
The Daily Telegraph also quoted other sources suggesting that GSK was using the threat of withdrawal to negotiate a lesser fine.
Hawaii legalizes gay marriage
Graduation celebration for Santas
One World Trade Center deemed tallest US skyscraper
US honors its veterans with ceremonies, parades
Carnival season kicks off in Cologne
Typhoon Haiyan hits Vietnam
UK's Royal Air Force marks ties with Bahrain
Red Cross Red Crescent holds meetings in Sydney
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263 Registration Number: 20100000002731 
